1Landis SH, Murray T, Bolden S, et al. Cancer statistics. Cancer J Clin, 1999,49( 1 ) :8.
2Finkler N, Benacerraf B, Lavin P, et al. Comparison of serum CA125,clinical impression and ultrasound in the preoperative evaluation of ovarian masses. Obstet Gynecol, 1988,72 (4) :659.
3Schutter E, Kenemans P, Sohn C, et al. Diagnostic value pelvic examination,ultrasound and serum CA125 in postmenopausal women with a pelvic mass: an international muhicenter study. Cancer,1994,74(4) :1398.
4Grab D, Flock F, Stohr I,et al. Classification of asymptomatic adnexal masses by ultrasound, magnetic resonance imaging, and positron emission tomography. Gynecol Onco1,2000,77 (3) :454.
5Luxman D, Bergman, Sagi J, et al. The postmenopausal adnexal mass: correlation between ultrasonic and pathologic findings [ see comments ]. Obstet Gynecol, 1991,77 (5) :726.
6Muller T, Rehn M, Pohls U, et al. Three-dimension ultrasonographic evaluation of ovarian tumors. Hum Reprod,1999,14(12) :3150.
7Cohen LS, Eseobar PF, Scharm C, et al. Three-dimensional ultrasound improves the diagnostic accuracy for ovarian cancer prediction. Gynecol Oncol,2001,82( 1 ) :40.
8Lund B ,Jacobsen K, Rasch L, et al. Correlation of abdominal ultrasound and computered tomography scans with second-or third look laparotomy in patients with ovarian carcinoma. Gynecol Oncol,.1990,37(2) :279.
9Hubner KF, McDonald TW, Niethammer JG, et al. Assessment of primary or metastatic ovarian cancer by positron emission tomography ( PET ) using 2 - [ 18 F ] -2 -deoxy-D-glucose ( 2-18 F-FDG ).Gynecol Onco1,1993,51 (2) :197.
10Casey MJ, Gupta C, Muths CK. Experience with positron emission tomography(PET) scans in patients with ovarian cancer. Gynecol Onco1,1994,53(3) :331.